다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Adverum Biotechnologies Inc (ADVM)
Adverum Biotechnologies Inc (ADVM) 뉴스

ADVM

Adverum Biotechnologies (ADVM)

Adverum Biotechnologies Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ADVM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	05:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/05/10	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/05/10	05:05	GlobeNewswire Inc.	Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/05/03	21:00	GlobeNewswire Inc.	Adverum Biotechnologies to Participate in Upcoming May Investor Conferences	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/04/26	05:05	GlobeNewswire Inc.	Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/03/19	05:05	GlobeNewswire Inc.	Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/03/05	06:40	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/29	06:05	GlobeNewswire Inc.	Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/23	05:47	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/22	05:39	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/16	06:17	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/15	10:26	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/15	06:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/15	06:30	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/15	06:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/15	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/12	22:00	GlobeNewswire Inc.	Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/10	07:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/10	01:41	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/08	22:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/08	21:00	GlobeNewswire Inc.	Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/07	06:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/06	07:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/05	21:45	GlobeNewswire Inc.	Adverum Biotechnologies Announces $127.5 Million Private Placement Financing	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/02/02	07:30	GlobeNewswire Inc.	Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024	NASDAQ:ADVM	Adverum Biotechnologies Inc
2024/01/29	22:00	GlobeNewswire Inc.	Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer	NASDAQ:ADVM	Adverum Biotechnologies Inc
2023/12/09	06:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADVM	Adverum Biotechnologies Inc
2023/12/08	06:05	GlobeNewswire Inc.	Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Society	NASDAQ:ADVM	Adverum Biotechnologies Inc
2023/12/05	06:09	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ADVM	Adverum Biotechnologies Inc
2023/11/29	06:05	GlobeNewswire Inc.	Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference	NASDAQ:ADVM	Adverum Biotechnologies Inc

검색 관련기사 보기:NASDAQ:ADVM

1 2 3 4 5 6 7 8 9 10 다음 >>

Vontobel Financial Produ...

GlobalBlock Digital Asse...

Sterling vs US Dollar

Intesa Sanpaolo

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관